Skip to main content
. Author manuscript; available in PMC: 2010 Nov 8.
Published in final edited form as: Arch Gerontol Geriatr. 2007 Apr 27;46(1):89–100. doi: 10.1016/j.archger.2007.02.009

Table 1.

Demographic and health-related characteristics of caregivers at time of pretest, according to completion of posttest questionnaire

Caregiver characteristics Noncompleters (N=47) Completers (N=118) Total (N=165) Pa
Age, mean±SD b 61.7±12.7 61.4±11.9 61.5±12.1 0.877
Female, % 87.2 90.7 89.7 0.573
White, % 89.1 92.3 91.4 0.105
≤ High school graduate, % 23.4 17.9 19.5 0.570
Not working, % 72.3 72.4 72.4 0.989
Income >$20,000 per year, % 66.0 67.8 67.3 0.365
Live together with CR, %c 61.7 58.5 59.4 0.743
Give personal care to CR daily/almost daily, % 15.9 24.1 21.8 0.247
Time for exercise ≥ 1 hour/week, % 38.3 44.1 42.7 0.672
Time for relaxation techniques or stress management ≥ 1 hour/week, % 31.9 23.7 25.8 0.452
Noncompleters (N=47) Completers (N=118) Total (N=165) P *

Health-risk behaviors, mean±SD 4.0± 2.4 3.5± 2.2 3.6± 2.2 0.147
Psychological well-being scale, mean±SD 8.4± 2.7 8.9± 2.6 8.8± 2.6 0.122
Relation to CR, %
 Spouse 42.6 42.3 42.4
 Offspring 44.7 39.0 40.6 0.142
 Offspring-in-law 6.4 2.5 3.6
 Other 6.4 15.3 12.7
 Missing 0.0 0.8 0.6
Care Recipient Conditions, % d
 Dementia 42.6 52.5 49.7 0.301
 Stroke 14.9 21.2 19.4 0.393
 Movement disorder 10.6 14.4 13.3 0.619
 Diabetes mellitus 21.3 15.3 17.0 0.364
 Heart disease 29.8 22.9 24.8 0.354
 Cancer 8.5 11.0 10.3 0.781
 Other e 21.3 24.6 23.6 0.691
a

P-value for difference between those who completed posttest and those who did not complete posttest questionnaire.

b

SD: standard deviation.

c

CR: care recipient.

d

Percents do not add to 100 because respondents were asked to select all that applied.

e

Other category, created from write-in responses, included the following conditions that have implications for physical functioning and therefore, caregiving: Musculoskeletal diseases (e.g., osteoarthritis), eye diseases (e.g., macular degeneration), central nervous system diseases (e.g., multiple sclerosis), depression, psychosis, end-stage renal disease, and chronic lung disease.